\documentclass[twocolumn,twoside]{article}
\makeatletter\if@twocolumn\PassOptionsToPackage{switch}{lineno}\else\fi\makeatother

\usepackage{amsfonts,amssymb,amsbsy,latexsym,amsmath,tabulary,graphicx,times,xcolor}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Following additional macros are required to function some 
% functions which are not available in the class used.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\usepackage{url,multirow,morefloats,floatflt,cancel,tfrupee}
\makeatletter


\AtBeginDocument{\@ifpackageloaded{textcomp}{}{\usepackage{textcomp}}}
\makeatother
\usepackage{colortbl}
\usepackage{xcolor}
\usepackage{pifont}
\usepackage[nointegrals]{wasysym}
\urlstyle{rm}
\makeatletter

%%%For Table column width calculation.
\def\mcWidth#1{\csname TY@F#1\endcsname+\tabcolsep}

%%Hacking center and right align for table
\def\cAlignHack{\rightskip\@flushglue\leftskip\@flushglue\parindent\z@\parfillskip\z@skip}
\def\rAlignHack{\rightskip\z@skip\leftskip\@flushglue \parindent\z@\parfillskip\z@skip}

%Etal definition in references
\@ifundefined{etal}{\def\etal{\textit{et~al}}}{}


%\if@twocolumn\usepackage{dblfloatfix}\fi
\usepackage{ifxetex}
\ifxetex\else\if@twocolumn\@ifpackageloaded{stfloats}{}{\usepackage{dblfloatfix}}\fi\fi

\AtBeginDocument{
\expandafter\ifx\csname eqalign\endcsname\relax
\def\eqalign#1{\null\vcenter{\def\\{\cr}\openup\jot\m@th
  \ialign{\strut$\displaystyle{##}$\hfil&$\displaystyle{{}##}$\hfil
      \crcr#1\crcr}}\,}
\fi
}

%For fixing hardfail when unicode letters appear inside table with endfloat
\AtBeginDocument{%
  \@ifpackageloaded{endfloat}%
   {\renewcommand\efloat@iwrite[1]{\immediate\expandafter\protected@write\csname efloat@post#1\endcsname{}}}{\newif\ifefloat@tables}%
}%

\def\BreakURLText#1{\@tfor\brk@tempa:=#1\do{\brk@tempa\hskip0pt}}
\let\lt=<
\let\gt=>
\def\processVert{\ifmmode|\else\textbar\fi}
\let\processvert\processVert

\@ifundefined{subparagraph}{
\def\subparagraph{\@startsection{paragraph}{5}{2\parindent}{0ex plus 0.1ex minus 0.1ex}%
{0ex}{\normalfont\small\itshape}}%
}{}

% These are now gobbled, so won't appear in the PDF.
\newcommand\role[1]{\unskip}
\newcommand\aucollab[1]{\unskip}
  
\@ifundefined{tsGraphicsScaleX}{\gdef\tsGraphicsScaleX{1}}{}
\@ifundefined{tsGraphicsScaleY}{\gdef\tsGraphicsScaleY{.9}}{}
% To automatically resize figures to fit inside the text area
\def\checkGraphicsWidth{\ifdim\Gin@nat@width>\linewidth
	\tsGraphicsScaleX\linewidth\else\Gin@nat@width\fi}

\def\checkGraphicsHeight{\ifdim\Gin@nat@height>.9\textheight
	\tsGraphicsScaleY\textheight\else\Gin@nat@height\fi}

\def\fixFloatSize#1{}%\@ifundefined{processdelayedfloats}{\setbox0=\hbox{\includegraphics{#1}}\ifnum\wd0<\columnwidth\relax\renewenvironment{figure*}{\begin{figure}}{\end{figure}}\fi}{}}
\let\ts@includegraphics\includegraphics

\def\inlinegraphic[#1]#2{{\edef\@tempa{#1}\edef\baseline@shift{\ifx\@tempa\@empty0\else#1\fi}\edef\tempZ{\the\numexpr(\numexpr(\baseline@shift*\f@size/100))}\protect\raisebox{\tempZ pt}{\ts@includegraphics{#2}}}}

%\renewcommand{\includegraphics}[1]{\ts@includegraphics[width=\checkGraphicsWidth]{#1}}
\AtBeginDocument{\def\includegraphics{\@ifnextchar[{\ts@includegraphics}{\ts@includegraphics[width=\checkGraphicsWidth,height=\checkGraphicsHeight,keepaspectratio]}}}

\DeclareMathAlphabet{\mathpzc}{OT1}{pzc}{m}{it}

\def\URL#1#2{\@ifundefined{href}{#2}{\href{#1}{#2}}}

%%For url break
\def\UrlOrds{\do\*\do\-\do\~\do\'\do\"\do\-}%
\g@addto@macro{\UrlBreaks}{\UrlOrds}



\edef\fntEncoding{\f@encoding}
\def\EUoneEnc{EU1}
\makeatother
\def\floatpagefraction{0.8} 
\def\dblfloatpagefraction{0.8}
\def\style#1#2{#2}
\def\xxxguillemotleft{\fontencoding{T1}\selectfont\guillemotleft}
\def\xxxguillemotright{\fontencoding{T1}\selectfont\guillemotright}

\newif\ifmultipleabstract\multipleabstractfalse%
\newenvironment{typesetAbstractGroup}{}{}%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\usepackage[authoryear]{natbib}



\newif\ifnokeywords\nokeywordsfalse

\makeatletter\input{size10-pointfive.clo}\makeatother%
\definecolor{kwdboxcolor}{RGB}{242,242,242}
\usepackage[hidelinks,colorlinks=true,allcolors=blue]{hyperref}
\linespread{1}                 
\def\floatpagefraction{0.8}

\usepackage[paperheight=11.69in,paperwidth=8.26in,top=1in,bottom=1in,left=1in,right=.75in,headsep=24pt]{geometry}

\usepackage{multirow-custom}

\makeatletter

\def\hlinewd#1{%
  \noalign{\ifnum0=`}\fi\hrule \@height #1%
  \futurelet\reserved@a\@xhline}
\def\tbltoprule{\hlinewd{1pt}\\[-14pt]}
\def\tblbottomrule{\noalign{\vspace*{6pt}}\hline\noalign{\vspace*{2pt}}}
\def\tblmidrule{\hline\noalign{\vspace*{2pt}}}



\let\@articleType\@empty
\let\@journalDoi\@empty
\let\@journalVolume\@empty
\let\@journalIssue\@empty
\let\@crossMarkLink\@empty
\let\@receivedDate\@empty
\let\@acceptedDate\@empty
\let\@revisedDate\@empty
\let\@publishedDate\@empty
\let\@copyrightYear\@empty
\let\@firstPage\@empty
\def\articleType#1{\gdef\@articleType{#1}}
\def\journalDoi#1{\gdef\@journalDoi{#1}}
\def\crossMarkLink#1{\gdef\@crossMarkLink{#1}}
\def\receivedDate#1{\gdef\@receivedDate{#1}}
\def\acceptedDate#1{\gdef\@acceptedDate{#1}}
\def\revisedDate#1{\gdef\@revisedDate{#1}}
\def\publishedDate#1{\gdef\@publishedDate{#1}}
\def\copyrightYear#1{\gdef\@copyrightYear{#1}}
\def\journalVolume#1{\gdef\@journalVolume{#1}}
\def\journalIssue#1{\gdef\@journalIssue{#1}}
\def\firstPage#1{\gdef\@firstPage{#1}}
\let\@issuelogo\@empty%
\let\@issuelogoex\@empty%
\def\issuelogo#1{\gdef\@issuelogo{#1}}
\def\issuelogoex#1{\gdef\@issuelogoex{#1}}


\def\author#1{%
  \gdef\@author{%
    \hskip-\dimexpr(\tabcolsep)\hskip5pt%
    \parbox{\dimexpr\textwidth-1pt}%
    {\fontsize{11}{13}\selectfont\raggedright #1}%
  }%
}


\usepackage{pharmascope-abs}
\usepackage{caption}
\usepackage{lastpage}
\usepackage{fancyhdr}
\usepackage[noindentafter,explicit]{titlesec}
\usepackage{fontspec}

\setmainfont[%
BoldFont=cambriab.ttf,%
ItalicFont=CAMBRIAI.TTF,%
BoldItalicFont=CAMBRIAZ.TTF]{Cambria.ttf}
\lefthyphenmin = 3

\def\title#1{%
  \gdef\@title{%
      \vspace*{-40pt}%
       \ifx\@articleType\@empty\else{\fontsize{10}{12}\scshape\selectfont\hspace{8pt}\@articleType\hfill\mbox{}\par\vspace{2pt}}\fi%
       \minipage{\linewidth}
         \hrulefill\\[-0.7pt]%%{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}\hfill
         \mbox{~}\hspace{5pt}\parbox{.1\linewidth}{\IfFileExists{images/\@issuelogo.\@issuelogoex}{\includegraphics[width=79pt,height=61pt]{images/\@issuelogo.\@issuelogoex}}{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}}\hfill
         \fcolorbox{kwdboxcolor}{kwdboxcolor}{\parbox{.792\linewidth}{%
          \begin{center}\fontsize{17}{17}\selectfont\scshape\vskip-7pt International Journal of Research in Pharmaceutical Sciences\hfill\end{center}%
          \vspace*{-10pt}\hspace*{4pt}{\fontsize{8}{9}\selectfont Published by JK Welfare \& Pharmascope Foundation\hfill  Journal Home Page: \href{www.ijrps.com}{\color{blue}\underline{\smash{www.ijrps.com}}}}\hspace*{4pt}\mbox{}}}%
       \par\vspace*{-1pt}\rule{\linewidth}{1.3pt}%
       \endminipage%
    \par\vspace*{9.2pt}\parbox{.98\linewidth}{\linespread{.9}\raggedright\fontsize{14}{17}\selectfont #1}%
    \vspace*{-8pt}%
  }
}


\setlength{\parindent}{0pt}
\setlength{\parskip}{0.4pc plus 1pt minus 1pt}

\def\abbrvJournalTitle{Int. J. Res. Pharm. Sci.}

\fancypagestyle{headings}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
}\pagestyle{headings}

                                                         
\fancypagestyle{plain}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}%
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
  \ifx\@firstPage\@empty\else\setcounter{page}{\@firstPage}\fi
}


\def\NormalBaseline{\def\baselinestretch{1.1}}
\usepackage{textcase}
\setcounter{secnumdepth}{0}

\titleformat{\section}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{13}\selectfont}
{\thesection}
{6pt}
{\MakeTextUppercase{#1}}
[]
\titleformat{\subsection}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsection}
{6pt}
{#1}
[]
\titleformat{\subsubsection}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsubsection}
{6pt}
{#1}
[]
\titleformat{\paragraph}[block]{\NormalBaseline\filright\fontsize{10.5}{10}\selectfont}
{\theparagraph}
{6pt}
{#1}
[]
\titleformat{\subparagraph}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubparagraph}
{6pt}
{#1}
[]

\titlespacing{\section}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsubsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\paragraph}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subparagraph}{0pt}{.5\baselineskip}{.5\baselineskip}

\captionsetup[figure]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}
\captionsetup[table]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}

\def\bibyear#1{#1}
%\def\bibjtitle#1{#1}   %%Publisher request
\def\bibauand{}
\setlength\bibsep{3pt}
\setlength\bibhang{8pt}

\makeatother
\date{}


\usepackage[flushleft]{threeparttablex}

\usepackage{float}

\begin{document}


\def\RunningAuthor{Parimala L et al.}
\firstPage{16}
\articleType{Original Article}
\receivedDate{01 Aug 2020}
\acceptedDate{09 Sep 2020}
\revisedDate{07 Sep 2020}
\journalVolume{2020, 11 (SPL4)}
\journalDoi{ijrps.v11iSPL4.3728}
\copyrightYear{2020}
\def\authorCount{2}
\def\affCount{1}

\def\journalTitle{International Journal of Research in Pharmaceutical Sciences}

\title{Effectiveness of Saline Washout Technique in the Management of Chemotherapy Extravasations Among Cancer Patients}
\author{Parimala~L\textsuperscript{*}, 
            Nivitha~W~\\[5pt]{Department of  Medical-Surgical Nursing, Saveetha College of Nursing, SIMATS, Chennai, India}}

\begin{abstract}
Cancer cells display uncontrolled growth invasion and sometimes metastatic spread to other location in the body  via lymph nodes or blood. Cancer affects people are mostly in elder ages peoples with risk for most type increasing with age cancer caused about 13\% of all human death 2008(7.6million). While improved the cancer patients first important for administer the chemotherapy.  But they may cause many of side effects in main side effects is ``EXTRAVASATION in'' extravasations is infiltration or leakage of intravenous chemotherapeutic agents. It mostly affected in extremities, into the local tissue surrounding the administration site may result of local tissue damage or extravasations. Drugs that is associated with severe necroes is when extravasations are known as vesicants. Whereas those associated with less severe burning or inflammation are known as irritation. The aim of the present study was conducted to assess the effect of saline washout technique in the management of chemotherapy extravasation among cancer patients. The present was conducted at SMCH with 100 male and female who come under inclusion criteria and they were selected by non-probability convenience sampling technique. The demographical variables was collected by using Semi-structured questionnaire and extravasations was assessed by INS (Infusion nurses society) infiltration and extravasation scale. The result revealed the pretest results show that 30\% had mild stage, 31\%  had moderate stage, 24\% had severe stage and  15\% had very severe stage on chemotherapy  extravasation among cancer patients. The post-test data revealed that 35\% had normal stage, 24\% had mild stage, 21\% had moderate stage,  14\% had severe stage and 6\% had very severe stage on chemotherapy extravasation among cancer patients.  The result revealed that saline washout technique was more effective in the management of chemotherapy extravasation among cancer patients.
\end{abstract}\def\keywordstitle{Keywords}

\begin{keywords}Effectiveness,\newline Saline Washout Technique,\newline Chemotherapy,\newline Extravasations Cancer Patients
\end{keywords}
\twocolumn[ \maketitle {\printKwdAbsBox}]
\makeatletter{\raggedright\textsuperscript{*}Corresponding Author\par Name:\ Parimala~L~\\ Phone:\ ~\\  Email:\ parimala.scon@saveetha.com
        \par}\vspace*{-11pt}\hrulefill\par{\fontsize{12}{14}\selectfont ISSN: 0975-7538}\par% 
        \textsc{DOI:}\ \href{https://doi.org/10.26452/\@journalDoi}{\textcolor{blue}{\underline{\smash{https://doi.org/10.26452/\@journalDoi}}}}\par%
        \vspace*{-11pt}\hrulefill\\{\fontsize{9.12}{10.12}\selectfont Production and Hosted by}\par{IJRPS |~\href{www.ijrps.com}{www.ijrps.com}}\par%
        \vspace*{-2pt}{\fontsize{9.12}{10.12}\selectfont\textcopyright\ \@copyrightYear\ $|$ All rights reserved.}\par%
        \vspace*{-11pt}\rule{\linewidth}{1.2pt}
        \makeatother
        
    
\section{Introduction}
Cancer is a class of illness wherein gathering of cell show uncontrolled development, attack and metastatic spread to different parts of the body through lymph nodes or blood. In the course of recent years since the presentation of chemotherapy as a treatment for the administration of carcinomas there has been a nonstop consistent ascent in its utilization. Late measurements show that there are around 309,500 new instances of Cancer (barring non-melanoma skin disease) analyzed every year in the UK, with most by far of cases (75\%) analyzed in individuals beyond 60 2011 years old (research UK 2011), thusly simultaneous with our maturing populace it very well may be normal that this figure will keep on rising. Corresponding to this the utilization of chemotherapy in the United Kingdom has been appeared to have expanded by up to 60\% over the multi-year from 2005-2009.\unskip~\citep{957271:20989763} This expanding utilization of cytotoxic medication treatment, the expanding multifaceted nature and viability of chemotherapy regimens, the nonstop presentation of new fundamental anticancer treatments coming about in caner now being delegated a ceaseless ailment, implies that over 1.8 million individuals reality that these individuals currently live 'with the past a malignancy conclusion.\unskip~\citep{957271:20989750} The related over various years all effects on the potential for number of cytotoxic medication extravasations to increment.\unskip~\citep{957271:20989760}

In spite of this, controversy proceeds concerning the most fitting treatment and the board methodologies that ought to be utilized when extravasation happens.\unskip~\citep{957271:20989748} This finish of the investigations is supported by  the recently published chemotherapy estimates which determine that all clinical chemotherapy administrations must have approaches and method in plan to guarantee staff controlling chemotherapy have had their competency surveyed and that there ought to be strategies and methodology set up for chemotherapy organization procedures and for fundamental treatment intense oncology introduction which incorporate the acknowledgment and treatment of cytotoxic extravasations, it ought to anyway be noticed that because of the perceived absence of proof these measures don't advocate which extravasations the executives system ought to be used\ensuremath{^{.}}\unskip~\citep{957271:20989749}

There are a few systems to forestall the extravasations that are identified with the (I) social insurance experts, and (ii) specialized devices utilized. Concerning human services experts, IV organization might be performed by people from various callings; they might be medical caretakers, radiologists.\unskip~\citep{957271:20989747} Analysts have examined whether this factor may influence extravasations.\unskip~\citep{957271:20989744} While human services suppliers avoid potential risk to anticipation to forestall extravasations, it can in any case happen in spite of the experience, ability and information on the specialist managing the cytotoxic chemotherapy.\unskip~\citep{957271:20989758} Thusly so as to improve practice, diminish the danger of extravasation and thus the key elements in the successful administration of extravasation is staff instruction, bolstered by cutting-edge institutional strategies and techniques so as to empower the early discovery of extravasation and to offices advance intervention.\unskip~\citep{957271:20989753}

The specific rate of chemotherapy extravasation shifts extraordinarily because of general absence of detailing and nonappearance of the library of chemotherapy extravasation occasions.\unskip~\citep{957271:20989746} While rules and approaches endeavor to limit its hazard, chemotherapy extravasation despite everything has a pervasiveness that can run from 0.1\% - 6\% when managed through fringe intravenous access and from 0.26\% - 4.7\% when controlled through a focal venous access gadget.

\unskip~\citep{957271:20989761} Establishment put together rules ought to be based with respect to prove, where accessible, however they are regularly ambiguous and vague, if present.\unskip~\citep{957271:20989751} This examination will be a wellspring of audit of the clinical parts of chemotherapy extravasation and most recent advances in grouping, counteraction and the executives of chemotherapy extravasation.\unskip~\citep{957271:20989745}

As chemotherapy related blunders are blocked at paces of around 2\% - 5\%, note that a few kinds of mistake are for all intents and purposes undiscoverable without constant checking of the planning procedure.\unskip~\citep{957271:20989755}  For instance, an individual who gets ready medication may choose from an inappropriate medication supply and coincidentally substitute one medication vial for another.

\unskip~\citep{957271:20989757}  Essentially, during cluster readiness, marks can be inaccurately applied to compartments of arranged dosages.\unskip~\citep{957271:20989756}  While there is an away from of sentiment that the standard preparing and training of all staff engaged with the organization of cytotoxic chemotherapy, upheld by cutting-edge institutional arrangements and methodology, is a factor in the viable counteraction of extravasation;\unskip~\citep{957271:20989759} it is likewise perceived that paying little mind to social insurance suppliers avoiding potential risk to forestall extravasation, and regardless of the experience, expertise and information on the professional regulating the chemotherapy, it will even now happen\unskip~\citep{957271:20989762}. The objective of the present study was to assess the effect of saline washout technique in the management of chemotherapy extravasation among  cancer patients.
    
\section{Materials and Methods}
A pre-experimental design was chosen to assess the effect of saline washout technique in the management of chemotherapy extravasation among  cancer patients. The present was conducted at SMCH among 100 males and  females who come under inclusion criteria were  selected by non-probability convenience sampling  technique. The demographical variables was collected by using Semi-structured questionnaire which includes socio-demographic variables such as age, sex, education, marital status, occupation, income, religion, type of  cancer, duration of illness, cycle of chemotherapy and extravasations was assessed by INS (Infusion nurses society) infiltration and extravasation scale. The assent was acquired preceding the data collection. 

The pretest level will be assessed the INS (Infusion nurses  society) to check the chemotherapy extravasation  grade followed by application of the saline washout technique in the management of chemotherapy  extravasation. Then the posttest chemotherapy  extravasation grade was assessed. The information obtained was investigated by utilizing descriptive and inferential statistics. Additionally,  Wilcox on rank sum test was performed to assess the  effectiveness of the study.
    
\section{Results and Discussion}
The present study characteristics are out of 100 sample reveals that 26\% belong to age group of 31-40years,56\% were females, 35\% were married, 28\% were housewives, 26\% were farmers,  30\% had non-formal education, 31\% had an income of RS.3001-5000, 32\% were Hindus. Type of cancer 58\% had gastrointestinal Cancer, 42\% gynecological cancer, Duration of illness 21\% had 1-4 months, 22\% had 5-8months, 31\%had9months,26\%had above1year, Cycle of chemotherapy 28\% had 1-2 cycle, 35\% had 3-4 cycle, 20\% had 5-6 cycle, 17\% had above 6cycles.(Figure~\ref{f-4412eca1791f})


\bgroup
\fixFloatSize{images/a404cbe2-f4c6-4ee8-a998-288f9b984b49-upicture1.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/a404cbe2-f4c6-4ee8-a998-288f9b984b49-upicture1.png}{\includegraphics{images/a404cbe2-f4c6-4ee8-a998-288f9b984b49-upicture1.png}}{}
\makeatother 
\caption{\boldmath {Cycle of chemotherapy level}}
\label{f-4412eca1791f}
\end{figure}
\egroup

\bgroup
\fixFloatSize{images/7eaa8fc3-eeb3-486d-8dca-a012c3e58517-upicture2.png}
\begin{figure}[!htbp]
\centering \makeatletter\IfFileExists{images/7eaa8fc3-eeb3-486d-8dca-a012c3e58517-upicture2.png}{\includegraphics{images/7eaa8fc3-eeb3-486d-8dca-a012c3e58517-upicture2.png}}{}
\makeatother 
\caption{\boldmath {Level of knowledge on chemotherapy extravasation among cancer patients}}
\label{f-a8efbfd6f183}
\end{figure}
\egroup

\begin{table}[!htbp]
\caption{\boldmath {Frequency and percentage distribution of pre-test level of chemotherapy extravasation among cancer patients. (N=100).} }
\label{tw-2515a9f9d9e7}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.3286\linewidth-2\tabcolsep}p{\dimexpr.29400000000000002\linewidth-2\tabcolsep}p{\dimexpr.37739999999999995\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}Level of Stage & \cAlignHack Frequency & \cAlignHack Percentage (\%)\\
\tblmidrule 
Normal &
  \cAlignHack - &
  \cAlignHack -\\
Mild &
  \cAlignHack 30 &
  \cAlignHack 30\%\\
Moderate &
  \cAlignHack 31 &
  \cAlignHack 31\%\\
Severe &
  \cAlignHack 24 &
  \cAlignHack 24\%\\
Very severe &
  \cAlignHack 15 &
  \cAlignHack 15\%\\
\tblbottomrule 
\end{tabulary}\par 
\end{table}

\begin{table}[!htbp]
\caption{\boldmath {Frequency and percentage distribution of post-test level of chemotherapy extravasation among cancer patients. (N=100).} }
\label{tw-80d80723fe28}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.31129999999999995\linewidth-2\tabcolsep}p{\dimexpr.33620000000000005\linewidth-2\tabcolsep}p{\dimexpr.3525\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor} Level of stage & \cAlignHack Frequency & \cAlignHack Percentage (\%)\\
\tblmidrule 
Normal &
  \cAlignHack 35 &
  \cAlignHack 35\%\\
Mild &
  \cAlignHack 24 &
  \cAlignHack 24\%\\
Moderate &
  \cAlignHack 21 &
  \cAlignHack 21\%\\
Severe &
  \cAlignHack 14 &
  \cAlignHack 14\%\\
Very severe &
  \cAlignHack 6 &
  \cAlignHack 6\%\\
\tblbottomrule 
\end{tabulary}\par 
\end{table}

\begin{table*}[!htbp]
\caption{\boldmath {Distribution of Mean and standard deviation for the effectiveness of pre-test and post-test of chemotherapy extravasation among cancer patients. (N=100).} }
\label{tw-b90560ecdc43}
\centering 
\begin{threeparttable}

\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.2864\linewidth-2\tabcolsep}p{\dimexpr.14639999999999997\linewidth-2\tabcolsep}p{\dimexpr.2386\linewidth-2\tabcolsep}p{\dimexpr.3286\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}Pre-test and Post-test  & Mean  & Standard Deviation  & Wilcox on rank sum Test \\
\tblmidrule 
Pre{\textendash}test &
  2.24 &
  \cAlignHack 0.1048 &
  Z= {\textendash} 5.16**** \mbox{}\protect\newline W-628\\
Post{\textendash}test &
  1.34 &
  \cAlignHack 1.2589 &
  Positive S* \mbox{}\protect\newline P - {\textless}0.00001\\
\tblbottomrule 
\end{tabulary}\par 
\begin{tablenotes}\footnotesize 
    
\item{S*=Significant}
\end{tablenotes}
\end{threeparttable}

\end{table*}
The pretest results show that 30\% had mild stage, 31\%  had moderate stage, 24\% had severe stage and  15\% had very severe stage on chemotherapy  extravasation among cancer patients.(Table~\ref{tw-2515a9f9d9e7})

The study results shows the post-test data revealed that 35\% had normal stage, 24\%hadmildstage,21\%hadmoderatestage,  14\% had severe stage and 6\% had very severe stage on chemotherapy extravasation among cancer patients. (Table~\ref{tw-80d80723fe28} \& Figure~\ref{f-a8efbfd6f183}) The mean and standard deviation for level of chemotherapy  extravasation among cancer patients. The overall  effectiveness of pre-test mean value is 2.24 and standard deviation is 0.1048. Post-test mean value  is 1.34and standard deviation is 1.2589 and Wilcox  on rank sum test value is Z~= {\textendash}5.16\ensuremath{^{\textbf{***}}}, W-628, P{\textless}0.00001, it will be Positive and significant. (Table~\ref{tw-b90560ecdc43})

The present is bolstered by Vinod et al. detailed an instance of compartment disorder and skin corruption of the hand after the extravasation of an iodinated item. For our situation, as detailed by different creators, the saline waste of time acted in a time span of 24 h yielded great results\unskip~\citep{957271:20989754}.  What's more, Dionyssiou et al. introduced a progression of 48 patients treated with saline waste of time for extravasation of anthracyclines and announced that 19 patients treated between the third day and the second week post-extravasation accomplished magnificent outcomes. In the waste of time technique, the saline arrangement is accepted to weaken the item in the site of extravasation, in this manner diminishing the vesicant impact.\unskip~\citep{957271:20989752}
    
\section{Conclusions}
The conclusion of the present study is the saline washout technique is effective in managing the chemotherapy extravasation among cancer patients.  The clinical chemotherapy administrations ought to incorporate have approaches and strategies set up to guarantee staff controlling chemotherapy have had their competency surveyed for fundamental treatment which incorporate the acknowledgement and treatment of cytotoxic extravasation. It ought to anyway be noticed that because of the perceived absence of proof these measures don't advocate which extravasations the executives technique ought to be utilized.

\textbf{Conflict of interest}

The authors declare that they have no conflict of interest for this study.

\textbf{Funding support}

The authors declare that they have no funding support for this study.
    

\bibliographystyle{pharmascope_apa-custom}

\bibliography{\jobname}
\end{document}
